Furthermore, numerous nicely founded adverse prognostic markers, together with U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, missing their unfavorable influence in patients dealt with with VO. The only issue that remained predictive of a shorter development-free survival Within this cohort of individuals was TP53 aberrations.112 At last, the ch